USANA Health Sciences (USNA) Expected to Announce Quarterly Earnings on Tuesday

USANA Health Sciences (NYSE:USNA) is projected to announce its earnings results after the market closes on Tuesday, February 25th. Analysts expect the company to announce earnings of $0.49 per share and revenue of $208.82 million for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

USANA Health Sciences Trading Down 0.8 %

Shares of USANA Health Sciences stock opened at $31.85 on Monday. The company’s 50-day moving average price is $33.81 and its two-hundred day moving average price is $36.73. USANA Health Sciences has a 52 week low of $30.13 and a 52 week high of $50.32. The stock has a market cap of $607.02 million, a PE ratio of 11.25, a price-to-earnings-growth ratio of 0.93 and a beta of 0.87.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on USNA shares. DA Davidson lifted their price target on USANA Health Sciences from $35.00 to $38.00 and gave the stock a “neutral” rating in a research note on Thursday, January 2nd. Sidoti cut USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 18th. Finally, StockNews.com cut USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.